Navigation Links
Varian Medical Systems Board of Directors Authorizes Repurchase of Additional 12 Million Shares of Stock Through Fiscal Year 2012; Additional Accelerated Share Repurchase Program
Date:2/14/2011

ding manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 5,400 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world.  For more information, visit http://www.varian.com.

Forward-Looking StatementsExcept for historical information, this news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements concerning future financial results and any statements using the terms "expect," "will," "believe," "estimate," or similar statements, are forward-looking statements that involve risks and uncertainties that could cause the company's actual results to differ materially from those anticipated. Such risks and uncertainties include whether the company will be able to enter into an agreement relating to the accelerated share repurchase program on favorable terms; the results of any accelerated share repurchase program, including the number of shares repurchased and the aggregate cost to the company; the company's ability to effect share repurchases in general on favorable terms, or at all; the company's ability to generate cash flow, and the other risks listed from time to time in the company's filings with the Securities and Exchange Commission, which by this reference are incorporated herein. The company assumes no obligation to update or revise the forward-loo
'/>"/>

SOURCE Varian Medical Systems
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
2. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
3. Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint
4. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
5. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
6. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
7. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
8. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
9. BSI-201 Demonstrates Significant Tumor Growth Inhibition and Increased Survival Rates in Preclinical Ovarian Cancer Studies
10. BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer
11. Join NPRs David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... -- Omeros Corporation (NASDAQ: OMER ) today announced that ... Inc. and its subsidiary, Par Sterile Products, LLC, (collectively ... of New Jersey and in ... Delaware . The lawsuits were filed under ... patents, U.S. Patent Nos. 8,173,707, 8,586,633 and 9,066,856, which ...
(Date:9/3/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/hs5hvr/investigation ... "Investigation Report on China Tamsulosin Market, 2010-2019" ... with other a1- adrenergic receptor blockers, tamsulosin hydrochloride ... risk of urinary tract infections and therefore is ... in 1993 in Japan , ...
(Date:9/3/2015)... BALTIMORE , September 3, 2015 ... that its subsidiary Lupin Pharmaceuticals, Inc. (Lupin) has ... which is the first and only generic Duloxetine ... strength. Lupin is excited to bring this new ... currently available dosing options for greater flexibility of ...
Breaking Medicine Technology:Omeros Files Infringement Suits Against Par 2Omeros Files Infringement Suits Against Par 3Omeros Files Infringement Suits Against Par 4China Tamsulosin Market Investigation Report 2015 2Lupin Launches First-ever Duloxetine 40mg Delayed-Release Capsules in the US 2Lupin Launches First-ever Duloxetine 40mg Delayed-Release Capsules in the US 3Lupin Launches First-ever Duloxetine 40mg Delayed-Release Capsules in the US 4
(Date:9/3/2015)... ... September 03, 2015 , ... TransPack Toon gives users ... can choose from wipes and framing transitions in 30 different styles. Presets range from ... Final Cut Pro X. , TransPack Toon features 90 cartoon transitions from 30 unique ...
(Date:9/3/2015)... York (PRWEB) , ... September 03, 2015 , ... William ... William Mattar, Esq. believes this does not stop at any certain demographic or ... to its newly produced one-minute, thirty-, fifteen- and ten-second TV commercials. , The closed ...
(Date:9/3/2015)... NH (PRWEB) , ... September 03, 2015 , ... ... new agreement with Amerinet Inc., a leading national healthcare solutions organization, to provide ... Epic EMR. , Through this agreement, Amerinet members will receive negotiated pricing on ...
(Date:9/3/2015)... South Bend, IN (PRWEB) , ... September 03, ... ... Mayo Clinic, Rochester, MN, and Indiana University, Indianapolis, have chosen Center for ... immediately, physicians from these institutions will train at CHC as part of fulfilling ...
(Date:9/3/2015)... ... September 03, 2015 , ... DriButts, a ... partnered with Slingshot® Product Development Group to manufacture a long-lasting reusable diaper for ... with DriButts plans to bring 600 DriButts Diapers to rural areas of Haiti ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios Releases TransPack Toon, a New FCPX Transition 2Health News:Law Firm Focused on “Helping People” Continues to Expand on Vision 2Health News:E-Volve Health to Offer EMR Consulting Solutions to Amerinet Members 2Health News:Physicians from Mayo Clinic and Indiana University to Complete Hospice & Palliative Medicine Training at Center for Hospice Care 2Health News:DriButts Diapers Rely on Slingshot Help in Haiti 2Health News:DriButts Diapers Rely on Slingshot Help in Haiti 3
... , , WASHINGTON , ... (National Council) is offering small emergency grants and free Mental Health ... of the devastating Haiti earthquake. , "Our thoughts are ... ones in the U.S. We commend the efforts of many agencies ...
... that launch glioblastoma multiforme, the most lethal type of brain ... scientists from The University of Texas M. D. Anderson Cancer ... the Jan. 15 issue of Clinical Cancer Research . ... also known as cancer stem cells, stifles the immune response ...
... Long-term use of low-dose versions affect women most, study finds, ... decrease bone density in young women, a new study suggests. ... years, and those on the low-dose estrogen pills appear to ... spine and whole body, according to the researchers. , "I ...
... Irritable bowel syndrome (IBS) is a common gastrointestinal ... well being. Multiple interacting mechanisms, including alterations in ... IBS aetiology. A research article to be ... World Journal of Gastroenterology addresses this question. ...
... increasing worldwide and its prognosis is very poor. ... early detection and on surgical treatment for better ... team from China retrospectively evaluated 5311 liver cancer ... December 2003. Of these, 429 (8.1%) patients were ...
... ... the new year by expanding their existing Green Bay, WI presence with the purchase ... ... technology company representing both businesses and residents has joined forces with Buildmyownsite, Inc., a ...
Cached Medicine News:Health News:Emergency Grants and Mental Health First Aid Training Available to Meet Mental Health Needs After Haiti Earthquake 2Health News:Emergency Grants and Mental Health First Aid Training Available to Meet Mental Health Needs After Haiti Earthquake 3Health News:Cancer stem cells suppress immune response against brain tumor 2Health News:Cancer stem cells suppress immune response against brain tumor 3Health News:The Pill May Decrease Bone Density 2Health News:The Pill May Decrease Bone Density 3Health News:Infinity Technology, Inc. Acquires Build My Own Site, Inc. 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: